181 results
424B3
PRTG
Portage Biotech Inc
6 Mar 24
Prospectus supplement
9:36pm
of these development programs ; the Company’s clinical development of its product candidates, including the results of current and future clinical trials ; the benefits
6-K
EX-99.1
PRTG
Portage Biotech Inc
6 Mar 24
Current report (foreign)
9:11pm
product candidates, including the results of current and future clinical trials ; the benefits and risks of the Company's product candidates as compared
6-K
EX-99.1
PRTG
Portage Biotech Inc
28 Feb 24
Company focused on adenosine platform clinical development
6:42pm
and future clinical trials; the benefits and risks of the Company’s product candidates as compared to others; the Company’s maintenance and establishment
424B3
PRTG
Portage Biotech Inc
28 Feb 24
Prospectus supplement
5:19pm
portion of base salary, accrued unused vacation time and any unpaid expenses). Additionally, he may be entitled to Severance Benefits (as defined … , paid over 12 monthly installments. The CEO will be entitled to life insurance benefits and medical and dental benefits for a period of 12 months
6-K
EX-99.1
PRTG
Portage Biotech Inc
28 Feb 24
Current report (foreign)
5:17pm
Benefits (as defined in the CEO Services Agreement), which include his then current base salary and the average of his annual bonus for the prior two … completed performance years, paid over 12 monthly installments. The CEO will be entitled to life insurance benefits and medical and dental benefits
6-K
EX-99.2
yfn sbmli3
28 Feb 24
Current report (foreign)
5:17pm
424B3
0tk vz3jzdw3s
18 Jan 24
Prospectus supplement
5:41pm
6-K
EX-99.1
874drbwwqn8qcy7
18 Jan 24
Current report (foreign)
5:09pm
424B3
3zmszw7
4 Jan 24
Prospectus supplement
5:49pm
6-K
EX-99.1
q5ypv4
4 Jan 24
Current report (foreign)
8:10am
S-8
EX-4.2
14cijc
1 Dec 23
Registration of securities for employees
4:05pm
424B3
v281zlln
28 Nov 23
Prospectus supplement
4:03pm
6-K
EX-99.1
o7ohy sjj
28 Nov 23
Current report (foreign)
4:01pm
6-K
EX-99.2
1s2mx7gq0f1irm78o
28 Nov 23
Current report (foreign)
4:01pm
424B3
0nyyh
14 Nov 23
Prospectus supplement
6:00am
6-K
EX-99.1
wctva8 89fssjvh
13 Nov 23
Current report (foreign)
6:10am
424B3
ik5xh
7 Nov 23
Prospectus supplement
4:50pm
F-1
sww1ws4lpou2tlalcdjq
31 Oct 23
Registration statement (foreign)
4:05pm
6-K
EX-10.1
cyiebt yzy
3 Oct 23
Current report (foreign)
4:05pm
6-K
EX-4.2
kt1 hqf7rn
3 Oct 23
Current report (foreign)
4:05pm